Core Viewpoint - Ming Kee Hospital is a leading private for-profit hospital group in East China, with significant market share and a focus on providing high-quality medical services through its two hospitals in Nanjing and Suzhou [2][3]. Company Overview - Ming Kee Hospital operates two private for-profit general hospitals: Nanjing Ming Kee Hospital and Suzhou Ming Kee Hospital, making it the largest private for-profit hospital group in East China by total revenue in 2024, with a market share of 1.0% in the region and 0.4% nationally [2]. - Nanjing Ming Kee Hospital, operational since 2008, was rated as a tertiary hospital in 2022, becoming the first private hospital in Nanjing to achieve this status. It ranks as the third largest private for-profit hospital in China with a market share of 0.3% [2]. - Suzhou Ming Kee Hospital, operational since 2013, is also a tertiary hospital and has received various certifications, including from the Joint Commission International (JCI) [2]. Financial Performance - Revenue for Ming Kee Hospital was approximately RMB 2.336 billion in 2022, RMB 2.688 billion in 2023, and RMB 2.659 billion in 2024, with RMB 1.330 billion and RMB 1.312 billion for the six months ending June 30 in 2024 and 2025, respectively [5]. - Profit figures were RMB 89.55 million in 2022, approximately RMB 167.45 million in 2023, and approximately RMB 108.92 million in 2024, with RMB 63.40 million and RMB 48.70 million for the six months ending June 30 in 2024 and 2025, respectively [6]. - Gross profit margins were 16.4% in 2022, 18.9% in 2023, and 18.1% in 2024, with a margin of 15.9% for the six months ending June 30 in 2025 [7][9]. Industry Overview - The private hospital sector in China is predominantly for-profit, holding a market share of 66.5% in 2024. The revenue of private hospitals is projected to grow from RMB 437.9 billion in 2019 to RMB 944.7 billion in 2024, with a compound annual growth rate (CAGR) of 16.6% [10]. - The number of private hospitals is expected to increase from 22,424 in 2019 to 27,652 in 2024, with a CAGR of 4.3% [13]. - The demand for higher quality medical services is anticipated to rise due to increasing disposable income and changing patient preferences, positioning private hospitals as key players in meeting this demand [13].

对基层医疗机构实施门诊"打包付费"后，由于基层可以获得更多财政投入支持，且医务人员的人工成本 更低，所以只要能把病看好，同样的支付标准下，基层医疗机构可以获得更多的结余资金。这种激励机 制可以推动基层医务人员向大医院看齐，既不过度诊疗"小病大治"，也不消极诊疗把患者推诿给大医 院。 梁嘉琳/文广东省医保局8月发布《关于建立健全门诊医保支付方式改革的通知》，宣布自2026年起，对 全省的门诊医疗服务实施"打包付费"。这是全国首个对门诊医疗服务实施"打包付费"改革的省份。据统 计，全国各级公立医疗机构门诊与住院收入比例约为4:6，此举预计将影响广东省公立医院四成收入的 格局，并对患者在省内的就医费用、服务品质产生重大影响。 国家医保局早已向全国所有医保统筹区推广"打包付费"，即医保按疾病诊断相关分组付费(DRG)、医保 按病种分值法付费(DIP)。然而，上述医保支付方式改革在设计之初仅适用于住院医疗服务，门诊医疗 服务在全国绝大部分地区仍然沿袭传统的按项目付费模式。在公立医院外部保障机制不到位、内部监督 机制不健全的情况下，不少医院仍有做大门诊服务数量和金额的现象。 有些医院通过门诊过度医疗赚钱，一个感冒患者就诊 ...